Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

  1. Piccolo, R. 1
  2. Eitel, I. 2
  3. Galasso, G. 3
  4. Iversen, A.Z. 4
  5. Gu, Y.L. 5
  6. Dominguez-Rodriguez, A. 6
  7. de Smet, B.J.G.L. 7
  8. Mahmoud, K.D. 5
  9. Abreu-Gonzalez, P. 8
  10. Thiele, H. 9
  11. Piscione, F. 3
  1. 1 University of Naples Federico II
    info

    University of Naples Federico II

    Nápoles, Italia

    GRID grid.4691.a

  2. 2 University of Leipzig
    info

    University of Leipzig

    Leipzig, Alemania

    GRID grid.9647.c

  3. 3 University of Salerno
    info

    University of Salerno

    Fisciano, Italia

    GRID grid.11780.3f

  4. 4 Department of Cardiology, Gentofte University Hospital
  5. 5 University of Groningen
    info

    University of Groningen

    Groninga, Holanda

    GRID grid.4830.f

  6. 6 Hospital Universitario de Canarias
    info

    Hospital Universitario de Canarias

    San Cristóbal de La Laguna, España

    GRID grid.411220.4

  7. 7 Department of Cardiology, Meander Medisch Centrum
  8. 8 Universidad de La Laguna
    info

    Universidad de La Laguna

    San Cristobal de La Laguna, España

    GRID grid.10041.34

  9. 9 University of Lubeck
    info

    University of Lubeck

    Lubeca, Alemania

    GRID grid.4562.5

Journal:
Vascular Pharmacology

ISSN: 1879-3649

Year of publication: 2015

Volume: 73

Pages: 32-37

Type: Article

Export: RIS
DOI: 10.1016/j.vph.2015.06.001 PMID: 26071862 SCOPUS: 2-s2.0-84941736892 GOOGLE SCHOLAR
Data source: Scopus